Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Susan F. Smith Center for Women's Cancers

  • Creating powerful possibilities for patients.

  • A Proven Leader in Women's Cancer Care

    As leaders in the world's fight to end women's cancers, the Susan F. Smith Center for Women's Cancers at Dana-Farber creates powerful possibilities for patients by bridging compassionate care and world-class research.

    Sara Tolaney, MD, MPH, and Alan D'Andrea, MD

    Sara Tolaney, MD, MPH, and Alan D'Andrea, MD

  • Make An Appointment

    Make An Appointment

    Get a Second Opinion

    Get a Second Opinion

    Call Us

    877-442-3324

  • Pioneering the Latest Advances

    Panos Konstantinopoulos, MD, PhD and Ursula Matulonis, MD

    Drug prolongs remissions in some relapsed ovarian cancers

    For women with relapsed ovarian cancer that responds to platinum-based chemotherapy, a drug that hampers cancer cells from repairing damaged DNA can significantly lengthen the period in which the disease is held in remission.

    Nikhil Wagle, MD

    A new approach to understanding breast cancer treatment resistance

    The information generated from this study has the potential to directly inform therapy choices for (ER)-positive patients.

    Judy Garber, MD, MPH

    The latest in genetics and women’s cancers

    In this Cancer Conversations podcast episode, Judy Garber, MD, MPH, discusses the latest in genetic research, including hereditary risks, genetic testing, and treatment options.

     

  • She told me it was going to be okay

    Erin and Dr. Partridge

    Erin - Breast cancer patient

    When Erin’s phone rang the night before her first visit to Dana-Farber’s Susan F. Smith Center for Women’s Cancers, she was surprised to hear the voice of the oncologist she would see the next day: Ann Partridge, MD, MPH.

    Read Erin's story

  • Latest News and Information

    Sara M. Tolaney, MD, MPH
    News Releases
    2/28/2023

    Therapy for small, HER2-positive breast tumors continues to be highly effective after 10 years, study finds

    • Breast Cancer
    Colleen Feltmate, MD
    Insight Blog
    2/15/2023

    Do Contraceptives Reduce or Increase the Risk of Cancer?

    • Ovarian Cancer
    • Cervical Cancer
    • Gynecologic Cancer
    • Breast Cancer
    Mills (left) enjoyed one of her favorite Peaks Island passions, swimming, with her family in 2012 — the year of her first breast cancer diagnosis.
    Insight Blog
    2/13/2023

    Living with Metastatic Breast Cancer, Valentines Ferry On

    • Patient Stories, Adult
    • Metastatic Breast Cancer
    • Breast Cancer
    Sara M. Tolaney, MD, MPH
    News Releases
    2/3/2023

    Dana-Farber research supports FDA approval of new therapy for metastatic breast cancer

    • Breast Cancer
    Ursula A. Matulonis, MD
    News Releases
    1/30/2023

    Results of the SORAYA study show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

    • Ovarian Cancer
    Jennifer Fullerton
    Insight Blog
    1/9/2023

    Breast Cancer Patient Achieves Her Dreams Thanks to Dana-Farber Care 

    • Patient Stories, Adult
    • Susan F. Smith Center
    • Breast Cancer
    Publications
    1/3/2023

    How Dana-Farber's environment of collaboration sparks new clinical trials and results in a far-reaching impact

    • BRCA
    • Research
    • Susan F. Smith Center
    • Ovarian Cancer
    Publications
    12/20/2022

    As cancer survivorship soars, Dana-Farber and others take a comprehensive approach to helping patients prepare for life after treatment

    • Genitourinary Cancer
    • Colon Cancer
    • Young Women With Breast Cancer
    Ursula A. Matulonis, MD
    Insight Blog
    12/13/2022

    Can Hair Relaxers and Straighteners Cause Uterine Cancer?

    • Endometrial (Uterine) Cancer
    • Gynecologic Cancer